Arnold & Porter LLP's biotech team offers clients a wide range of legal experience. Working in tandem with the regulatory, transactional, and litigation practice groups across the firm, our experience with scores of US, European, and international clients allows us to offer strategic advice and integrated solutions, covering all aspects of drug discovery and human health, ranging from small molecule to biologics to platform technologies to medical devices. We also assist clients in agribusiness, food production and distribution, chemicals, and other industries that increasingly use life sciences technologies.
Our services to biotech and medical technology companies are comprehensive. We offer clients experience across the board, in product development, from cradle to grave-much more than a few particular strengths in a specialty practice or two. Our experience includes significant depth in, among other areas, patent procurement, structuring and fund raising, corporate and securities, US and EU regulatory matters, licensing and other partnering transactions, mergers and acquisitions, tax, patent litigation and commercial litigation, antitrust, product liability, and government contracting.
To the benefit of all of our clients, our experience with an extensive list of pharmaceutical and biotech companies-both high-profile and smaller companies-ensures that our counsel is as diverse, dynamic, and innovative as the work that they do. The list includes a who's who of big pharma and specialty pharma in their biotech investments and matters, big biotech, smaller and emerging biotech companies, medical device and medical technology companies, and universities and other nonprofits. Befitting the global scope of our firm's practice, we provide clients with advice on matters throughout the US, Europe, Japan, India, and China.